Key statistics
On Monday, Mink Therapeutics Inc (INKT:NAQ) closed at 0.7481, 5.22% above its 52-week low of 0.711, set on Sep 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.769 |
---|---|
High | 0.7695 |
Low | 0.7402 |
Bid | 0.7401 |
Offer | 0.7899 |
Previous close | 0.7538 |
Average volume | 24.53k |
---|---|
Shares outstanding | 39.54m |
Free float | 10.02m |
P/E (TTM) | -- |
Market cap | 29.81m USD |
EPS (TTM) | -0.4891 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 21:00 BST.
More ▼
- MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference
- MiNK Reports Second Quarter 2024 Results and Business Update
- MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report
- MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement
- MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
- MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
- MiNK Reports First Quarter 2024 Results
- MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
- MiNK to Provide Corporate Update and First Quarter 2024 Financial Report
- MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR
More ▼